Skip to Content

Clopidogrel Qualimed

Active Substance: clopidogrel hydrochloride
Common Name: clopidogrel
ATC Code: B01AC06
Marketing Authorisation Holder: Qualimed
Active Substance: clopidogrel hydrochloride
Status: Withdrawn
Authorisation Date: 2009-09-23
Therapeutic Area: Peripheral Vascular Diseases Stroke Myocardial Infarction
Pharmacotherapeutic Group: Antithrombotic agents

Therapeutic Indication

Clopidogrel is indicated in adults for the prevention of atherothrombotic events in:

  • Patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.

For further information please refer to section 5.1.

The marketing authorisation for Clopidogrel Qualimed has been withdrawn at the request of the marketing-authorisation holder.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.